Patterson Companies Q2 Earnings Beat Street View, Raises FY22 Adjusted EPS Outlook

  • Patterson Companies Inc PDCO reported Q2 FY22 sales of $1.65 billion, +6.2% Y/Y, beating the consensus of $1.58 billion.
  • Dental segment sales reached $622.2 million. Internal sales decreased 2% Y/Y, including a 0.8% decline in consumables and a 3% decline in equipment and software. 
  • Animal Health segment sales reached $1 billion. Internal sales growth of 16.2% was driven by continued strong performance in companion animals and additional recovery in production animals. It included 15.8% growth in consumables and 37.8% growth in equipment and software. 
  • The gross margin declined to 19.8% from 20.6% a year ago.
  • Patterson Companies reported an adjusted EPS of $0.58, surpassing the consensus of $0.50.
  • Guidance: Patterson Companies updated its fiscal 2022 adjusted EPS guidance to $2.00 - $2.10, compared to prior guidance of $1.95 - $2.05 and the consensus of $2.03.
  • Price Action: PDCO shares are down 0.95% at $31.17 during the market session on the last check Wednesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!